Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials

Background: Diabetes is a very common cause of cardiovascular disease, and metformin remains the first-line treatment of diabetes. Many trials were conducted to prove the efficacy and safety of other antidiabetic medication as the best add-on medication. Objectives: We aimed to evaluate the atherosc...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbarawi, Mahmoud, Aburahma, Ahmed, Zayed, Yazan, Osman, Mohammed, Rashdan, Laith, Swaid, Bakr, Bachuwa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292369/
https://www.ncbi.nlm.nih.gov/pubmed/30559943
http://dx.doi.org/10.1080/20009666.2018.1542919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292369/
https://www.ncbi.nlm.nih.gov/pubmed/30559943
http://dx.doi.org/10.1080/20009666.2018.1542919

Ejemplares similares